Fig. 6From: An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15Modelled symptomatic and pre-symptomatic patient pool per country of interest, and per HSP genetic subtype. SPG4 (a), SPG11 (b), SPG7 (c), and SPG15 (d). Pre-symptomatic (black) and symptomatic (green) populations are highlightedBack to article page